Pharmaceutical

Sanders takes aim at US drug prices of Novo’s Ozempic a...

A Senate Committee is investigating the “outrageously high” US price tags of the...

Cidara buys back rights to flu therapy from J&J for $85m

Marking another chapter in the long-running saga, J&J has deprioritised the CD38...

Seres Therapeutics gets grant for composition of isolat...

Discover the groundbreaking patent by Seres Therapeutics Inc for a unique compos...

Apellis Pharmaceuticals gets grant for treatment of com...

Discover how Apellis Pharmaceuticals' patented method using long-acting compstat...

Ipsen gets grant for treatment of diseases with specifi...

Discover how Ipsen SA's patented compounds can treat cardiovascular, metabolic, ...

Viatris gets grant for nasal spray method for treating ...

Discover a groundbreaking patent by Viatris Inc for treating dry eye disease wit...

Sanofi gets grant for optical decoding system for deter...

Enhance medication dosing accuracy with Sanofi's patented optical decoding syste...

Bicycle Therapeutics gets grant for high affinity binde...

Discover the groundbreaking patent by Bicycle Therapeutics Plc for high affinity...

Novartis bags paediatric FDA label expansion for Lutathera

Lutathera is approved by the US FDA to treat patients aged 12 years and older wi...

Johnson & Johnson gets grant for heart ultrasound image...

Improve cardiac imaging quality with Johnson & Johnson's patented ultrasound met...

Pfizer gets grant for treatment of cancer using enginee...

Discover how Pfizer's patented CARs targeting BCMA offer a groundbreaking method...

Investors anticipate “bounce-back” in European private ...

At the Swiss Biotech Day conference, panelists at an investment talk discussed t...

Datopotamab deruxtecan by Daiichi Sankyo for Metastatic...

Datopotamab deruxtecan is under clinical development by Daiichi Sankyo and curre...

Datopotamab deruxtecan by Daiichi Sankyo for Non Muscle...

Datopotamab deruxtecan is under clinical development by Daiichi Sankyo and curre...

Datopotamab deruxtecan by Daiichi Sankyo for Head And N...

Datopotamab deruxtecan is under clinical development by Daiichi Sankyo and curre...

Datopotamab deruxtecan by Daiichi Sankyo for Epithelial...

Datopotamab deruxtecan is under clinical development by Daiichi Sankyo and curre...